|
Worldwide Biotech - December 2007Published by: Worldwide Videotex Published: Dec. 1, 2007 - 8 Pages Table of Contents
THROMBOGENICS STARTS PHASE IIA OF MICROPLASMIN FOR STROKE TELBIVUDINE APPROVED IN SWITZERLAND FOR CHRONIC HEPATITIS B BASILEA REPORTS 92% CLINICAL CURE RATES FOR CEFTOBIPROLE AbstractWORLDWIDE BIOTECH provides news and information on biotechnology as an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||